EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 121 filers reported holding EPIZYME INC in Q1 2022. The put-call ratio across all filers is 4.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,119,000 | -77.1% | 761,558 | -82.1% | 0.00% | -100.0% |
| Q1 2022 | $4,894,000 | +135.1% | 4,256,266 | +411.2% | 0.00% | – |
| Q4 2021 | $2,082,000 | +290.6% | 832,635 | +698.7% | 0.00% | – |
| Q3 2021 | $533,000 | -55.2% | 104,250 | -27.2% | 0.00% | – |
| Q2 2021 | $1,190,000 | +2.5% | 143,149 | +7.4% | 0.00% | – |
| Q1 2021 | $1,161,000 | -87.5% | 133,296 | -84.5% | 0.00% | -100.0% |
| Q4 2020 | $9,318,000 | +230.2% | 858,068 | +262.7% | 0.00% | +100.0% |
| Q3 2020 | $2,822,000 | -3.8% | 236,563 | +29.5% | 0.00% | 0.0% |
| Q2 2020 | $2,933,000 | +66.6% | 182,637 | +60.9% | 0.00% | – |
| Q1 2020 | $1,760,000 | -4.3% | 113,515 | +51.8% | 0.00% | – |
| Q4 2019 | $1,840,000 | -69.7% | 74,795 | -87.3% | 0.00% | -100.0% |
| Q3 2019 | $6,071,000 | +1417.8% | 588,591 | +1745.1% | 0.00% | – |
| Q2 2019 | $400,000 | +158.1% | 31,900 | +155.2% | 0.00% | – |
| Q1 2019 | $155,000 | -90.4% | 12,500 | -95.3% | 0.00% | -100.0% |
| Q4 2018 | $1,623,000 | +68.4% | 263,492 | +189.6% | 0.00% | – |
| Q3 2018 | $964,000 | -91.2% | 90,977 | -88.8% | 0.00% | -100.0% |
| Q2 2018 | $10,977,000 | +6.3% | 810,119 | +39.3% | 0.01% | -16.7% |
| Q1 2018 | $10,325,000 | +45.7% | 581,714 | +3.0% | 0.01% | +50.0% |
| Q4 2017 | $7,085,000 | -17.7% | 564,589 | +24.9% | 0.00% | -33.3% |
| Q3 2017 | $8,612,000 | +2879.9% | 452,049 | +1440.3% | 0.01% | – |
| Q3 2016 | $289,000 | +149.1% | 29,349 | +305.1% | 0.00% | – |
| Q4 2015 | $116,000 | -65.6% | 7,245 | -72.4% | 0.00% | – |
| Q3 2015 | $337,000 | +51.8% | 26,209 | +183.7% | 0.00% | – |
| Q2 2015 | $222,000 | -70.6% | 9,239 | -77.1% | 0.00% | -100.0% |
| Q1 2015 | $756,000 | -21.4% | 40,287 | -21.0% | 0.00% | 0.0% |
| Q4 2014 | $962,000 | -84.4% | 50,975 | -77.6% | 0.00% | -83.3% |
| Q3 2014 | $6,170,000 | +1172.2% | 227,575 | +1360.5% | 0.01% | +500.0% |
| Q2 2014 | $485,000 | – | 15,582 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |